Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS in Metabolic Syndrome

NCT02912325 is registered in ClinicalTrials.gov with MDM S.p.A. as lead sponsor.

NCT NCT02912325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02912325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS in Metabolic Syndrome
Lead sponsor
MDM S.p.A.
Phase
Not applicable
Overall status
Completed
Start date
May 9, 2017
Completion date
June 11, 2018
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome